RxDoctor Payments DataLook up a doctor →

Michael McKinney, MD

Pediatrics · Nicholasville, KYNPI 1396763603

Payments from drug & device makers

$6,178in general payments, 2019–2025

Across 380 payments — averaging $16.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lilly USA, LLC$1K
  • AbbVie$576
  • AstraZeneca$542
  • Pfizer$458
  • Amgen$345
  • Merck$327
  • plus $3K from 37 others

What the payments were for

  • Food & beverage$6,178100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,178 in reported general payments places this provider in the 95th percentile of 777 pediatrics providers in Kentucky.

See all pediatrics providers in Kentucky

Medicare billing

Part B allowed, 2024
$169,040
Medicare patients
347
Services billed
3,150

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban195$155,858
TrulicityDulaglutide43$55,942
JanuviaSitagliptin Phosphate34$51,197
JardianceEmpagliflozin55$47,688
MounjaroTirzepatide19$31,739
XareltoRivaroxaban19$25,539
OzempicSemaglutide19$18,080
Trelegy ElliptaFluticasone/Umeclidin/Vilanter12$11,444
TradjentaLinagliptin13$8,533
Quetiapine Fumarate ErQuetiapine Fumarate12$7,707
PremarinEstrogens, Conjugated18$6,502
Levothyroxine Sodium411$5,886
Pantoprazole Sodium438$5,791
Testosterone17$5,769
SynthroidLevothyroxine Sodium97$5,581

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis, Premarin$458$162,360213 claims
Lilly USA, LLCTrulicity, Mounjaro$1,037$87,68262 claims
Boehringer IngelheimJardiance, Tradjenta$243$56,22168 claims
MerckJanuvia$327$51,19734 claims
Johnson & JohnsonXarelto$263$25,53919 claims
Novo NordiskOzempic$318$18,08019 claims
GSKTrelegy Ellipta$116$11,44412 claims
AbbVieSynthroid$576$5,58197 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 777 pediatrics providers in Kentucky.

Other pediatrics in Nicholasville

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →